Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
April 9, 2019
Patent Application Number
15386347
Date Filed
December 21, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
Therapeutic uses of modified relaxin polypeptides for the treatment of cardiovascular disease, treatment of heart failure, and decreasing fibrotic disorders are provided. Exemplary embodiments provide for the use of relaxin polypeptides which include one or more amino acid substitutions with natural or non-naturally encoded amino acids, and/or linkage to a water-soluble polymer, such as polyethylene glycol.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
